These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19762603)

  • 1. Abdominal fat deposition is associated with increased inflammation, protein-energy wasting and worse outcome in patients undergoing haemodialysis.
    Cordeiro AC; Qureshi AR; Stenvinkel P; Heimbürger O; Axelsson J; Bárány P; Lindholm B; Carrero JJ
    Nephrol Dial Transplant; 2010 Feb; 25(2):562-8. PubMed ID: 19762603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nutritional status evaluation and survival in haemodialysis patients in one centre from Romania.
    Segall L; Mardare NG; Ungureanu S; Busuioc M; Nistor I; Enache R; Marian S; Covic A
    Nephrol Dial Transplant; 2009 Aug; 24(8):2536-40. PubMed ID: 19297358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients.
    de Mutsert R; Grootendorst DC; Axelsson J; Boeschoten EW; Krediet RT; Dekker FW;
    Nephrol Dial Transplant; 2008 Sep; 23(9):2957-64. PubMed ID: 18400817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality.
    Suliman ME; Qureshi AR; Carrero JJ; Bárány P; Yilmaz MI; Snaedal-Jonsdottir S; Alvestrand A; Heimbürger O; Lindholm B; Stenvinkel P
    QJM; 2008 May; 101(5):397-405. PubMed ID: 18292098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of inflammation and protein-energy wasting with endothelial dysfunction in peritoneal dialysis patients.
    Choi HY; Lee JE; Han SH; Yoo TH; Kim BS; Park HC; Kang SW; Choi KH; Ha SK; Lee HY; Han DS
    Nephrol Dial Transplant; 2010 Apr; 25(4):1266-71. PubMed ID: 19926717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients.
    Carrero JJ; Chmielewski M; Axelsson J; Snaedal S; Heimbürger O; Bárány P; Suliman ME; Lindholm B; Stenvinkel P; Qureshi AR
    Clin Nutr; 2008 Aug; 27(4):557-64. PubMed ID: 18538898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition.
    de Mutsert R; Grootendorst DC; Indemans F; Boeschoten EW; Krediet RT; Dekker FW;
    J Ren Nutr; 2009 Mar; 19(2):127-35. PubMed ID: 19218039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low levels of IgM antibodies against phosphorylcholine-A increase mortality risk in patients undergoing haemodialysis.
    Carrero JJ; Hua X; Stenvinkel P; Qureshi AR; Heimbürger O; Bárány P; Lindholm B; Frostegård J
    Nephrol Dial Transplant; 2009 Nov; 24(11):3454-60. PubMed ID: 19549697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low serum fetuin-A concentration predicts poor outcome only in the presence of inflammation in prevalent haemodialysis patients.
    Metry G; Stenvinkel P; Qureshi AR; Carrero JJ; Yilmaz MI; Bárány P; Snaedal S; Heimbürger O; Lindholm B; Suliman ME
    Eur J Clin Invest; 2008 Nov; 38(11):804-11. PubMed ID: 19021697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal pro-brain natriuretic peptide independently predicts protein energy wasting and is associated with all-cause mortality in prevalent HD patients.
    Guo Q; Bárány P; Qureshi AR; Snaedal S; Heimburger O; Stenvinkel P; Lindholm B; Axelsson J
    Am J Nephrol; 2009; 29(6):516-23. PubMed ID: 19077418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD.
    Axelsson J; Møller HJ; Witasp A; Qureshi AR; Carrero JJ; Heimbürger O; Bárány P; Alvestrand A; Lindholm B; Moestrup SK; Stenvinkel P
    Am J Kidney Dis; 2006 Dec; 48(6):916-25. PubMed ID: 17162146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nutritional status, comorbidity, and inflammation in hemodialysis].
    Fernández-Reyes MJ; Alvarez-Ude F; Sánchez R; Mon C; Iglesias P; Vázquez A
    Nefrologia; 2000; 20(6):540-9. PubMed ID: 11217649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation.
    Suliman M; Stenvinkel P; Qureshi AR; Kalantar-Zadeh K; Bárány P; Heimbürger O; Vonesh EF; Lindholm B
    Nephrol Dial Transplant; 2007 Jan; 22(1):209-17. PubMed ID: 16982634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of overall obesity and body fat distribution in predicting risk of mortality.
    Reis JP; Macera CA; Araneta MR; Lindsay SP; Marshall SJ; Wingard DL
    Obesity (Silver Spring); 2009 Jun; 17(6):1232-9. PubMed ID: 19197258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central obesity is an independent predictor of erectile dysfunction in older men.
    Riedner CE; Rhoden EL; Ribeiro EP; Fuchs SC
    J Urol; 2006 Oct; 176(4 Pt 1):1519-23. PubMed ID: 16952671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High protein diets decrease total and abdominal fat and improve CVD risk profile in overweight and obese men and women with elevated triacylglycerol.
    Clifton PM; Bastiaans K; Keogh JB
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):548-54. PubMed ID: 19179060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality.
    Tong M; Carrero JJ; Qureshi AR; Anderstam B; Heimbürger O; Bárány P; Axelsson J; Alvestrand A; Stenvinkel P; Lindholm B; Suliman ME
    Clin J Am Soc Nephrol; 2007 Sep; 2(5):889-97. PubMed ID: 17702732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients.
    Qureshi AR; Alvestrand A; Divino-Filho JC; Gutierrez A; Heimbürger O; Lindholm B; Bergström J
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S28-36. PubMed ID: 11792759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity and abdominal obesity; an alarming challenge for cardio-metabolic risk in Turkish adults.
    Oğuz A; Temizhan A; Abaci A; Kozan O; Erol C; Ongen Z; Celik S
    Anadolu Kardiyol Derg; 2008 Dec; 8(6):401-6. PubMed ID: 19103534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease.
    Postorino M; Marino C; Tripepi G; Zoccali C;
    J Am Coll Cardiol; 2009 Apr; 53(15):1265-72. PubMed ID: 19358939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.